Inhalant Solution

Known as: Inhalation Solutions, Inhalant Solution [Dose Form], Inhalant Solution Dosage Form 
Liquid medication intended to be inhaled.

Topic mentions per year

Topic mentions per year

1975-2017
05101519752017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
RATIONALE Fosfomycin/tobramycin for inhalation (FTI), a unique, broad-spectrum antibiotic combination, may have therapeutic… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND A light-porous-particle, dry-powder formulation of tobramycin was developed, using PulmoSphere® technology, to improve… (More)
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 3
Is this relevant?
2011
2011
RATIONALE Lower respiratory tract infection with Pseudomonas aeruginosa (PA) is associated with increased morbidity in patients… (More)
Is this relevant?
2011
2011
Tobramycin inhalation solution is used to treat chronic Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Chronic airway infection with Pseudomonas aeruginosa (PA) causes morbidity and mortality in patients with cystic fibrosis (CF… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
Respiratory disease is the main cause of morbidity and mortality in patients with cystic fibrosis (CF). In particular, patients… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
RATIONALE The effectiveness and safety of aztreonam lysine for inhalation (AZLI) in patients with cystic fibrosis (CF) on… (More)
Is this relevant?
2008
2008
Adding a long-acting beta(2)-agonist (LABA) by dry powder inhaler (DPI) to tiotropium provides significantly increased and… (More)
Is this relevant?
2007
2007
RATIONALE Denufosol tetrasodium is a selective P2Y(2) agonist that enhances mucosal hydration and mucus clearance by activating… (More)
Is this relevant?
1999
1999
STUDY OBJECTIVES Patients with COPD are at risk of experiencing a deterioration in arterial oxygen saturation (SaO2) during sleep… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?